Metformin and insulin: Is there a role for combination therapy?

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 474-480

  Daniel, Jacqueline R ^a   Hagmeyer, Kathleen O ^b  

^a SUMMA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

diabetes mellitus; insulin; metformin

Indexed keywords

INSULIN; METFORMIN; PHENFORMIN;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0030975530     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100414     Document Type: Review

References (19)

1. Package insert. Glucophage (metformin). Princeton, NJ: Bristol-Myers Squibb Company, 1995.
2. Bailey C. Biguanides and NIDDM. Diabetes Care 1992;15:755-72.
3. Vigneri R, Goldfine ID, Role of metformin in treatment of diabetes mellitus. Diabetes Care 1987;10:18-22.
4. Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care 1990;13(suppl 3):37-41.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
6. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 1992;231:25-30.
7. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
8. Ferguson AW, de la Harpe PL, Farquhar JW. Dimethyldiguanide in the treatment of diabetic children. Lancet 1961;1:1367-9.
9. Fabrykant M, Ashe B. Use of long-acting phenformin (DBI-TD) with insulin in insulin-dependent diabetes. Metabolism 1961;10:684-8.
10. Bloom A, Kolbe RJ. Phenformin in insulin-dependent diabetics. Br Med J 1970;1:660-2.
11. Pirart J. Failure of the biguanides to improve the control of unstable diabetes treated with insulin. Diabetologia 1971;7:283-6.
12. Schatz H, Winkler G, Jonatha EM, Pfeiffer EF. Studies on juvenile-type diabetes in children: assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Diabete Metab 1975;1:211-20.
13. Gin H, Slama G, Weissbrodt P, Poynard T, Vexiau P, Klein JC, et al. Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas. Diabetologia 1982;23:34-6.
14. Pagano G, Tagliaferro V, Carta Q, Caselle MT. Bozzo C, Vitelli F, et al. Metformin reduces insulin requirements in type I (insulin-dependent) diabetes. Diabetologia 1983;24:351-4.
15. Coscelli C, Palmari V, Saccardi F, Alpi O, Bonora E. Evidence that metformin addition to insulin induces an amelioration of glycemic profile in type I (insulin-dependent) diabetes mellitus. Curr Ther Res 1984;35:1058-64.
16. Keilacker H, Rjasanowski I, Ziegler M, Michaelis D, Woltanscki KP, Besch W. Insulin antibodies in juvenile diabetes mellitus: correlation to diabetic stability, insulin requirement and duration of insulin treatment. Horm Metab Res 1982;14:227-32.
17. Gin H, Messerchmitt C, Brottier E, Aubertin J. Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients. Metabolism 1985;34:923-5.
18. Janssen M, Rillaerts E, De Leeuw I. Effect of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). Biomed Pharmacother 1991;45:363-7.
19. Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, De Rosa N, et al. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 1993;44:107-12.